Search Results 2841-2850 of 16439 for Chronic Lymphocytic Leukemia

1. Sharing Mayo Clinic: Treating lung cancer during COVID-19 pandemic

   It was a difficult diagnosis at a most difficult time. Despite the challenges, Sheila was able to safely receive the help and medical care she needed. And ...

2. A Study to Evaluate Effectiveness and Safety of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia (Enrolling by Invitation Only) - Mayo Clinic

   Phase 4 trials look at long-term safety and effectiveness, after a new ... Confirmed diagnosis of bacterial pneumonia or other active/uncontrolled ...

3. Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer - Mayo Clinic

   ... chronic steroids. Note: must be off systemic steroids at least 90 days prior ... Psychiatric illness/social situations that would limit compliance with study ...

4. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

   Alisertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Hormone therapy using fulvestrant may fight breast cancer ...

5. Heart Failure Clinical Trials

   The study will evaluate the effect of oral IW-1973 on peak exercise capacity in patients with HFpEF, with or without permanent or persistent atrial fibrillation ...

6. Optimal cutaneous lymphoma care: A multidisciplinary, comprehensive approach - Mayo Clinic

   Diagnosing CTCL. "It's not unusual for patients with CTCL to have multiple biopsies over several years before a diagnosis is made," says Dr. Bennani ...

7. An Extension Study of Trastuzumab Emtansine in Patients Treated with the Same Drug Regimen in a Previous Study - Mayo Clinic

   Phase 4 trials look at long-term safety and effectiveness, after a new ... Current severe, uncontrolled systemic disease (e.g. clinically significant ...

8. Science Saturday: New genetic test classifies lymphomas - Mayo Clinic News Network

   Mayo Clinic was the first in the U. S. to offer the Lymph2Cx genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell ...

9. A Study Comparing a Vaccine with or without an Autologous Tumor Lysate to Treat Stage III or IV Melanoma to Prevent Recurrence - Mayo Clinic

   Phase 4 trials look at long-term ... Immune deficiency disease or known history of HIV, HBV, HCV; Receiving immunosuppressive therapy including chronic steroids, ...

10. Mayo Clinic Florida Tissue Repository for Research on ALS and Related Neurodegenerative Disorders

    Clinical diagnosis of possible, laboratory-supported probable, probable or definite ALS according to modified EL Escorial criteria, suspected ALS according ...